0,1,2,3,4,5,6,7,8
Table 6.3: Adjuvant conventional radiotherapy for node-positive penile cancer,,,,,,,,
Author,n,stage,aRT,Adj  CT,RT,LR,OS,Study type
Jaipuria   2020 [274],45,anyT pN2-3  pelvis pN-,25,7,"VMAT/IMRT,   45 Gy basic,   54 Gy ENE,   57-60 macro",No InF,47 mo. RT  vs. 14 mo. CT,Prosp  registry
Johnstone   2019 [275],93,anyTpN3  ENE-  ENE+,,,50/25 no details,,↑OS aRT   p = 0.037  or aCT   p = 0.038  ↑DSS aRT   p = 0.04,4 centres
Winters   2018 [280],136,pT1-3   pN1-2,,,45 Gy + boost   45%,,↑OS aRT  5 yr.  64% vs. 53%,NCDB
Tang   2017 [277],92,N3 +pelvis,40,,"63% 50/25,   13% > 50 Gy",,↑OS aRT  12.2 vs.8  P=0.04  ↑DSS  14.4 vs.8  p = 0.02,4 centres
Ager   2021 [276],146,pN3 (ENE   or pelvis+),121,,45/20 to 54/25  2X↑LR if < 50,26 inF,OS 44%  RFS 5y 51%,2 centres   UK
Bandini   2021 [34],507,ILND,86  HPV+  40  aRT,,,,↑OS aRT  p = 0.015  Also propensity  matched   analysis,11 centres
